| 摘要 |
A method and therapeutic compositions for inducing interferon formation in vivo. To a host is administered an interferon inducer selected from the group consisting of A. 1,5-BIS[(3-MORPHOLINOPROPYL)AMINO]ANTHRAQUINONE, B. 1-[(2-AMINOETHYL)AMINO]-5-[[1-(HYDROXYMETHYL)-PROPYL]AMINO]ANTHRAQUINONE INCLUDING PRIMARY -N-acylates, O-acylates, and O,primary-N-diacylates thereof, wherein the acylates are the acyl moiety of a carboxylic acid having from 2 to 18 carbon atoms, inclusive, C. 1,5-BIS[[2-(DIETHYLAMINO)ETHYL]AMINO]ANTHRAQUINONE, D. 1,5-BIS[[3-(DIETHYLAMINO)PROPYL]AMINO]ANTHRAQUINONE, E. 1,5-BIS[(3-PIPERIDINOPROPYL)AMINO]ANTHRAQUINONE.
|
